We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

93 hedge funds and large institutions have $42.2M invested in Carisma Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 1.29% → 1.22% (-0.07%)

5% less capital invested

Capital invested by funds: $44.5M → $42.2M (-$2.3M)

10% less funds holding

Funds holding: 103 → 93 (-10)

10% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 29

33% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 27

58% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $3.08M

Holders
93
Holders Change
-10
Holders Change %
-9.71%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
26
Reduced
29
Closed
27
Calls
$1.28M
Puts
$3.08M
Net Calls
-$1.8M
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.18M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.9M
4
Prudential Financial
Prudential Financial
New Jersey
+$678K
5
Group One Trading
Group One Trading
Illinois
+$449K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$2.29M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.93M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.25M
4
Norges Bank
Norges Bank
Norway
-$996K
5
Deutsche Bank
Deutsche Bank
Germany
-$750K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$125K – – –
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$113K -$3.44K -171 -2%
Deutsche Bank
28
Deutsche Bank
Germany
$106K -$750K -37,236 -85%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$100K -$121 -6 -0.1%
Vontobel Holding
30
Vontobel Holding
Switzerland
$94K – – –
Wells Fargo
31
Wells Fargo
California
$89K -$258K -12,823 -70%
AIG
32
American International Group
New York
$87K -$1.31K -65 -1%
Cambridge Investment Research Advisors
33
Cambridge Investment Research Advisors
Iowa
$83K -$1.01K -50 -1%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$83K +$10.3K +512 +11%
SO
35
STRS Ohio
Ohio
$78K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$77K +$17.7K +879 +23%
UBS Group
37
UBS Group
Switzerland
$76K +$92.5K +4,594 +5,220%
State Board of Administration of Florida Retirement System
38
State Board of Administration of Florida Retirement System
Florida
$71K – – –
AWS
39
AJ Wealth Strategies
New York
$65K – – –
TSS
40
Two Sigma Securities
New York
$60K -$56.8K -2,821 -43%
Invesco
41
Invesco
Georgia
$59K -$27.2K -1,351 -27%
Los Angeles Capital Management
42
Los Angeles Capital Management
California
$59K -$785 -39 -1%
Parallax Volatility Advisers
43
Parallax Volatility Advisers
California
$59K -$403 -20 -0.5%
ProShare Advisors
44
ProShare Advisors
Maryland
$59K +$47K +2,335 +184%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$55K -$1.01K -50 -1%
First Manhattan
46
First Manhattan
New York
$50K – – –
Citigroup
47
Citigroup
New York
$48K +$31.6K +1,571 +112%
Principal Financial Group
48
Principal Financial Group
Iowa
$47K -$465K -23,120 -89%
EGM
49
Engineers Gate Manager
New York
$43K +$53.2K +2,645 New
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$40.2K +$14.3K +712 +41%
1
2
3 4 5

CARM Hedge Fund Activity: Q4 2021 in Review

93 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2021, worth a combined $42.2M — down 5.2% from $44.5M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of CARM and 18 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $2.57M. The largest seller was Two Sigma Investments, cutting an estimated $2.29M.

  • 93 institutional investors held Carisma Therapeutics (CARM) as of Q4 2021, down from 103 in Q3 2021.
  • Funds reported $42.2M of Carisma Therapeutics stock for Q4 2021, down 5.2% quarter-over-quarter.
  • 18 funds opened new Carisma Therapeutics positions in Q4 2021 and 27 closed out, a net change of -9 holders.
  • The largest Carisma Therapeutics buyer in Q4 2021 was BlackRock, an estimated $2.57M added.
  • The largest Carisma Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2021.